IBOGF trade ideas
Universal Ibogaine Delivering Excellence The Company newly reported that its common shares, coined as "JC4", have been accepted for trade on the Frankfurt Stock Exchange, or Boerse Frankfurt. In Canada, UI will keep trading on the TSX Venture Exchange under the ticker IBO and on the OTCQB under the stock symbol IBOGF.
$IBO, Recognized as a powerful addiction interrupterOur mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.
While seeking to move Ibogaine through Clinical Trials in Canada, we are building a network of holistic recovery clinics and a state of the art treatment program centred around new treatment modalities.
Potential aptitude of NCP-01 by Hemostemix Neuropathic pain synNeuropathic pain syndromes can be treated with NCP-01 and its autologous stem cell technology, which can treat disorders of the central and peripheral nervous systems. Spinal cord injury, chronic brainstem injury, traumatic brain injury, and peripheral nerve injury are all examples of traumatic injuries and many more
Universal Ibogaine’s shares got approved for trading by Frankfur
Under the ticker symbol "JC4", UI's common shares have been registered for trade on the Frankfurt Stock Exchange, or Bourse Frankfurt. In Canada, UI will continue trading under the ticker name IBO on the TSX Venture Exchange and on the OTCQB under the ticker symbol IBOGF on the OTCQB
$IBOGF accord with blue digital media calls for added benefitsBlue Digital will be paid USD 27,000 for a three-month commitment beginning June 13, 2022. Additionally, Blue Digital will get 450,000 company's stock options to purchase common shares of the Company, with an exercise price of $0.10 per share, a three-year term, and one-third vesting at the conclusion of each month of service.
$IBOGF CEO Thoughts on H.C Wainwright.It gives UI great pleasure to announce that Nick Karos, CEO, will speak at the H.C. Wainwright 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics and Beyond. On June 27, 2022, a hybrid online and offline event will take place. "H.C. Wainwright is a leader in the field and may be a significant strategic partner in our ongoing corporate finance roadmap," said Nick Karos, CEO of Universal Ibogaine. Another crucial step in raising awareness of our brand and service is the chance to share our story with this audience.
$IBO to commission ultra- modern addiction treatment centre
At the Kelburn Clinic, UI is developing a cutting-edge holistic addiction treatment protocol that, when combined with the anticipated ibogaine detox programme, will transform the way we treat addiction and dramatically enhance the lives of individuals and families plagued by addiction.
$IBO’S CEO comments on the H.C Wainwright
"H.C. Wainwright is a leader in the field and may be a significant strategic partner in our ongoing corporate finance roadmap," said Nick Karos, CEO of Universal Ibogaine. Another crucial step in raising awareness of our brand and service is the chance to share our story with this audience.
$IBO and its revolutionary addiction treatment protocolUI is developing an advanced holistic addiction treatment protocol, at its Kelburn Recovery Centre, that when combined with the planned ibogaine detox methodology is expected to transform the way we treat addiction and dramatically promote the welfare of families affected by addiction.
Blue digital media to highlight $IBO narrativeThe UI story will be distributed through numerous platforms and audiences by Blue Digital. The expected outcome is increased knowledge of UI's plans to conduct research into the use of ibogaine as part of a continuum of care for opioid addiction and other addictions.
$IBO an investor’s alluring stock investment$IBO has been elastic through the ebbs and flows of the market and have always maintained a tight toe hold in the Canadian venture exchange, its consistency to this day is what intrigues investors globally, the shares are trading at $0.05 with no such recorded loss
UI advantages of listing on the Frankfurt stock exchangeThe Frankfurt Stock Exchange (FSE) is Germany's largest stock exchange and the leading European destination for Canadian venture capital firms seeking exposure and liquidity in the European market. The FSE enables advanced electronic trading, settlement, and information technologies, allowing it to handle the increasing demands of cross-border trading.